Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2020

View Archived Issues

AHR inhibition suppresses Zika infection

[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer

[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM

EBV drives gastric cancer by rewiring host epigenomes

Suzhou Zelgen Biosciences identifies new MAP3K5 inhibitors

Dihydroorotate dehydrogenase inhibitors discovered at Janssen

Cascade (Shanghai) Pharmaceutical Technology patents AMPK activators

New PDE9 inhibitors synthesized at Nanjing TransThera Biosciences

Gruenenthal presents glucocorticoid receptor modulators

Series A financing to support ExeVir's development of VHH-72-Fc for COVID-19

Enrollment starts in phase IIa study of tegavivint in desmoid tumors

PIK3C2B blockade protects against ischemic stroke and preserves vascular integrity

FDA clears first IND application for RLS-0071

Reata announces investigator-sponsored trial of bardoxolone in patients with COVID-19

First patient dosed in investigator-initiated study of infigratinib in recurrent glioblastoma

European Commission grants approval for Xenleta as treatment of CAP

COVACTA trial of Actemra in severe COVID-19-associated pneumonia misses endpoints

Phase III REFALS trial of oral levosimendan in ALS does not meet endpoints

Mucolipin-1 is a therapeutic target in Alzheimer's disease

Krystal begins phase III study of beremagene geperpavec for dystrophic epidermolysis bullosa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...